ASPIRE FINAL DRAFT

Results from the ASPIRE Study for Breast Reconstruction Utilizing the AeroForm™ Controlled Carbon Dioxide-Inflated Tissue Expanders Tony F. Connell, MBBS, BSc, FRACS Subiaco, Western Australia, Australia CORRESPONDING AUTHOR CONTACT INFORMATION Tony F. Connell, MBBS, BSc, FRACS 3/200 Rokeby Road Subiaco … Continue reading

Share

Updated Clinical Data from Numerous Studies of AirXpanders’ AeroForm™ Needle-Free, Patient-Controlled Tissue Expansion System to Be Presented at American Society of Plastic Surgeons (ASPS) Annual Meeting 2014

Presentations include the latest interim results from XPAND head-to-head pivotal study and data on whether AeroForm-implanted patients can undergo radiation therapy for residual breast cancer while completing the expansion process   PALO ALTO, Calif., Oct. 6, 2014 /PRNewswire/ — The … Continue reading

Share

Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders

Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders   Highly statistically significant improvement in expansion and total implant times compared to saline Interim results of the XPAND trial published in the April … Continue reading

Share

AeroForm Approved in Australia

World’s First Needle-Free, Patient-Controlled Tissue Expansion Device for Women Undergoing Breast Reconstruction Following Mastectomy Approved in Australia  Australia represents the first commercial market for AirXpanders’s AeroForm®  Company to launch AeroForm to select plastic surgeons  PALO ALTO, Calif. (November 4, 2013) … Continue reading

Share